Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.

Xuechen Wang, Shengnan Wei, Chao Zhao, Xin Li, Jin Jin, Xuening Shi, Zhenyue Su, Juan Li, Juan Wang

Journal: Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2022;27(4-5):405-419

PMID: 35713714

Abstract

As shown in studies conducted in recent decades, polyoxometalates (POMs), as inorganic metal oxides, have promising biological activities, including antitumor, anti-infectious and anti-Alzheimer's activities, due to their special structures and properties. However, some side effects impede their clinical applications to a certain extent. Compared with unmodified POMs, POM-based inorganic-organic hybrids and POM-based nanocomposite structures show significantly enhanced bioactivity and reduced side effects. In this review, we introduce the biological activities of POMs and their derivatives and highlight the side effects of POMs on normal cells and organisms and their possible mechanisms of action. We then propose a development direction for overcoming their side effects. POMs are expected to constitute a new generation of inorganic metal drugs for the treatment of cancer, infectious diseases, and Alzheimer's disease.Graphical abstract.

© 2022. The Author(s), under exclusive licence to Society for Biological Inorganic Chemistry (SBIC).

Address: School of Public Health, Jilin University, Changchun, Jilin, China.; School of Public Health, Jilin University, Changchun, Jilin, China. [email protected].; School of Public Health, Jilin University, Changchun, Jilin, China. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.